Silvant Capital Management’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
VPM
VCM
AM
FAM
Silvant Capital Management's ALAB Position: Q1 2026 in Review
Silvant Capital Management increased its Astera Labs (ALAB) stake by 21% in Q1 2026, buying an estimated $628K and bringing the position to 25,206 shares worth $2.76M. The position accounts for 0.1% of the portfolio, ranked #116.
Silvant Capital Management first reported a position in ALAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.46M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.
- Silvant Capital Management held 25,206 shares of Astera Labs worth $2.76M as of Q1 2026.
- Silvant Capital Management bought 4,408 Astera Labs shares in Q1 2026, an estimated $628K.
- Astera Labs made up 0.1% of Silvant Capital Management's portfolio in Q1 2026, its #116 holding.
- Silvant Capital Management first reported a position in Astera Labs in Q3 2025 and has held it in 3 quarters since.
- Silvant Capital Management's Astera Labs position peaked at $3.46M in Q4 2025.
- 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.